72
Growth Score
pts
Heat Score
70 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
3989942
Vaxsyna, Inc develops an IgG-based vaccine platform for multi-antigen vaccines and therapeutics and emerging infectious diseases.
About the Company
Vaxsyna, Inc develops vaccines and therapeutics based on a patented recombinant immune complex platform. The platform uses a human IgG antibody fused to target antigens and an epitope tag to form self-assembling higher order antibody complexes. These complexes present multiple antigens on the IgG termini and engage Fc receptors to induce
pathogen-specific immune responses. The technology is designed for minimal-dose, adjuvant-free vaccination and can be adapted to various antigen sizes and combinations. Vaxsyna collaborates with academic and industry partners and builds on published work in herpes simplex virus, Zika virus, norovirus, and human papillomavirus models.
